|
Demographic variable
|
Group
|
P value
|
|---|
|
Placebo
|
Active
|
|---|
| |
(n 40)
|
(n 41)
|
–
|
|
Age (years)
|
65.2 (8.4)
|
64.7 (6.3)
|
0.784
|
|
Sex n male (female)
|
17 (23)
|
16 (25)
|
–
|
|
Weight (kg)
|
73.0 (63.4–84.0)
|
72.8 (63.3–84.2)
|
0.916
|
|
Height (m)
|
1.69 (0.09)
|
1.68 (0.08)
|
0.587
|
|
BMI (kg/m2)
|
25.5 (23.5–29.5)
|
25.4 (23.4–29.5)
|
0.860
|
|
Waist (cm)
|
92.70 (82.63–102.50)
|
89.75 (81.50–105.05)
|
0.702
|
|
Hip (cm)
|
104.28 (8.56)
|
104.42 (8.74)
|
0.944
|
|
Waist:hip
|
0.89 (0.09)
|
0.90 (0.10)
|
0.605
|
|
Systolic BP (mmHg)
|
130.9 (19.7)
|
127.6 (20.3)
|
0.469
|
|
Diastolic BP (mmHg)
|
76.2 (8.6)
|
74.6 (10.1)
|
0.321
|
|
Plasma total 25(OH)D (nmol/L)
|
62.5 (22.4)
|
59.3 (25.2)
|
0.539
|
|
Serum Homocysteine (µmol/L)
|
11.05 (9.68–12.75)
|
11.86 (10.29–15.05)
|
0.047
|
|
Serum folate (nmol/L)
|
18.0 (14.3–21.9)
|
15.5 (11.8–21.6)
|
0.123
|
|
Serum vitamin B12 (pmol/L)
|
336 (235–449)
|
310 (246–409)
|
0.357
|
|
Plasma PLP (vitamin B6; nmol/L)
|
61.7 (48.6–85.1)
|
59.4 (44.5–74.1)
|
0.487
|
|
Riboflavin (EGRac)
|
1.29 (1.24–1.35)
|
1.34 (1.25–1.43)
|
0.168
|
- Data presented as mean (SD) and median (IQR). P value of differences between treatment groups, p < 0.05 considered statistically significant. BP, blood pressure; EGRac, erythrocyte glutathione reductase activation coefficient; PLP, Pyridoxal 5′-phosphate
